STAT+: Radiopharma companies merge after one receives surprise FDA rejection
ITM Isotope Technologies Munich SE and Telix Pharmaceuticals, two leading companies in the burgeoning radiopharmaceuticals field, are merging in a deal worth at least $1.65 billion. Under the deal, Telix will acquire all shares of the privately…
ImpactMinor 17/100
Why it mattersRule-based estimate: event keywords (+6), soft/evergreen signals; trust 8/10.
RegionsGlobal
Published6 h ago (Sun, 20 Sep 2026 23:25:57 GMT)
RetrievedMon, 21 Sep 2026 02:00:13 GMT via rss
ClassifiedMon, 21 Sep 2026 02:00:31 GMT by heuristic
AuthorAllison DeAngelis